NEW YORK (Reuters Health) - People who take part in clinical trials often do so out of a desire to advance scientific knowledge and to help others, a new international study demonstrates. "These ...
PANOVA-3 study showed significant OS improvement with tumor-treating fields plus chemotherapy in pancreatic cancer patients. Median OS was 16.2 months with combination therapy versus 14.16 months with ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Feb 5 (Reuters) - Vertex Pharmaceuticals' (VRTX.O), opens new tab experimental cystic-fibrosis treatment met all of its main goals in a late-stage study when tested in patients aged 12 years and older ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results